Yu Du

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Cells

Top Venues

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Enjie Li, Mingyue Xia, Yu Du, Kaili Long, Feng Ji, Fei-Yan Pan, Lingfeng He, Zhigang Hu, Zhigang Guo
METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis. eLife 11 (2022)